Association of ADAM17 Expression Levels in Patients with Interstitial Lung Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of ADAM17 Expression Levels in Patients with Interstitial Lung Disease

Published:2019-08-30 Issue:1-2 Volume:49 Page:134-145
ISSN:0882-0139
Container-title:Immunological Investigations
language:en
Short-container-title:Immunological Investigations

Author:

Ge Jianjian¹,Tang Lijian²,Mu Peipei¹,Zhu Fuli³,Xie Lian¹,Tang Yurong¹

Affiliation:

1. Department of Clinical Laboratory, Shengli Oilfield Central Hospital, Dongying, Shandong, China

2. Department of Pulmonary Medicine, Shengli Oilfield Central Hospital, Dongying, Shandong, China

3. Department of Radiology, Shengli Oilfield Central Hospital, Dongying, Shandong, China

Publisher

Informa UK Limited

Subject

General Medicine,Immunology

Link

https://www.tandfonline.com/doi/pdf/10.1080/08820139.2019.1660367

Reference33 articles.

1. PULMONARY FUNCTION TESTS IN INTERSTITIAL LUNG DISEASE

2. ADAM17 as a Therapeutic Target in Multiple Diseases

3. Serum Analysis of Coagulation Factors in IPF and NSIP

4. Role of ADAM17 in the ectodomain shedding of TNF- and its receptors by neutrophils and macrophages

5. Evaluation of multiple-flows exhaled nitric oxide in idiopathic and non-idiopathic interstitial lung disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Exacerbations of Interstitial Lung Diseases: Focus on Biomarkers;International Journal of Molecular Sciences;2023-06-15

2. MiR-26a-5p from HucMSC-derived extracellular vesicles inhibits epithelial mesenchymal transition by targeting Adam17 in silica-induced lung fibrosis;Ecotoxicology and Environmental Safety;2023-06

3. Potential biomarkers for diagnosis and disease evaluation of idiopathic pulmonary fibrosis;Chinese Medical Journal;2023-05-02

4. Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches;International Journal of Molecular Sciences;2022-11-29

5. Blockade of the protease ADAM17 ameliorates experimental pancreatitis;Proceedings of the National Academy of Sciences;2022-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3